-
Viral RIPK3 Degradation Controls Orthopoxvirus Inflammation
2026-09-22
Liu and colleagues identified vIRD, an orthopoxvirus factor that recruits host SCF machinery to drive ubiquitination and proteasome-dependent degradation of RIPK3. Their genetic and in vivo evidence links this targeted protein-degradation strategy to necroptosis, viral replication, inflammation, and pathogen–host evolution.
-
Cholesterol and the Translational LNP Frontier
2026-09-22
Cholesterol is more than a membrane constituent: it is a strategic formulation variable for researchers translating lipid nanoparticle delivery into localized therapies. This article connects cholesterol biology, assay design, and the intravesical p21 mRNA–LNP bladder cancer study to define practical priorities for translational development.
-
Minoxidil sulphate for Vascular Research
2026-09-21
Minoxidil sulphate offers a practical potassium-channel pathway tool for linking vascular reactivity, renal perfusion, and hair follicle biology. This workflow shows how to control solubility, vehicle effects, exposure timing, and assay context for more reproducible research-only experiments.
-
Estradiol–Autophagy Axis in Perimenopausal Aging
2026-09-21
A 2026 Life Sciences study integrates NHANES analysis, perimenopausal mouse experiments, network pharmacology, and inhibitor-based validation to examine how declining estradiol affects the heart, aorta, and kidneys. Its central contribution is evidence that estrogen receptor signaling and downstream autophagy jointly mediate protection against multi-organ fibrosis, while also highlighting important limits for translating hormone-treatment findings to human care.
-
Thiothixene for Macrophage Efferocytosis
2026-09-20
Thiothixene connects dopamine signaling pathway modulation with macrophage clearance biology, giving researchers a practical tool for studying continual efferocytosis in mouse and human systems. This guide translates the reference findings into assay setup, control design, troubleshooting, and translational interpretation without equating an in vitro concentration with a clinical dose.
-
SGC-CBP30: CREBBP/EP300 Bromodomain Workflows
2026-09-19
SGC-CBP30 provides a selective way to test how CREBBP and EP300 bromodomain activity shapes enhancer-driven transcription, TGF-β/SMAD3 signaling, and cancer phenotypes. This practical guide connects biochemical selectivity with cell-based, chromatin, and lung adenocarcinoma research workflows while emphasizing controls and troubleshooting.
-
Marein Restores Mitoxantrone Sensitivity via ABCG2
2026-09-19
A 2024 Biochemical Pharmacology study identifies marein, a flavonoid from Coreopsis tinctoria Nutt, as a competitive inhibitor of the ABCG2 drug-efflux transporter. By increasing intracellular exposure to ABCG2 substrates, including Mitoxantrone, marein restored chemotherapy sensitivity in resistant cancer-cell models and linked transporter inhibition to interaction with residue F439.
-
Optimal RIP3 Stoichiometry in Necrosome Assembly
2026-09-18
The reference study combines quantitative STORM imaging with mathematical modeling to show that necrosomes operate most efficiently at an approximately 3:1 RIP3:RIP1 stoichiometry. It further demonstrates that excessive RIP3 oligomerization attenuates signaling, revealing a built-in size-control mechanism that balances signal amplification with restraint during necroptosis.
-
Talabostat mesylate: DPP4/FAP Research Workflows
2026-09-18
Talabostat mesylate, also known as PT-100, supports controlled studies of DPP4 and FAP in tumor, immune, and hematopoietic models. This workflow-focused guide also clarifies how its use differs from DPP8/9 inflammasome research described in a recent SFTSV study.
-
PYR-41: E1 Inhibition at the Immune Interface
2026-09-17
PYR-41 offers translational researchers a way to interrogate how ubiquitin activation shapes protein stability, NF-κB signaling, inflammation, and antiviral defense. This mechanistic perspective connects E1 inhibition with IRF7 degradation during infectious bursal disease virus infection while clearly separating established evidence from testable hypotheses.
-
CTCF, Centromere Function, and Mitotic Fidelity
2026-09-17
Walsh and colleagues use rapid auxin-induced CTCF degradation to show that CTCF preserves centromere mechanics and accurate mitosis, rather than simply recruiting the CENP-E chromosome-congression motor. The findings connect CTCF-dependent chromatin organization with intercentromere tension, metaphase-plate architecture, mitotic success, and postmitotic nuclear shape.
-
Zwitterionic Lipids Improve mRNA Cancer Vaccines
2026-09-16
The reference study describes membrane-destabilizing zwitterionic (MeDZ) lipids that switch from a neutral zwitterionic state to a strongly positive state in mildly acidic endosomes. Added to established mRNA-LNPs, MeDZ lipids improved antigen expression in lymph-node antigen-presenting cells, strengthened antitumor immune responses, and reduced local reactogenicity in mice.
-
Novel Ziprasidone Impurity: Identification and Analysis
2026-09-15
The reference study identified and structurally characterized methylene ziprasidone dimer, an unknown process-related impurity detected during scale-up of ziprasidone hydrochloride. Its integrated HPLC, HRMS, and multidimensional NMR workflow shows how orthogonal analytical evidence can convert an unresolved chromatographic signal into a defined impurity suitable for process and quality assessment.
-
Ibrexafungerp Workflows for Candida Research
2026-09-15
Ibrexafungerp, also known as MK 3118, supports resistance-aware Candida testing across neutral and acidic assay conditions. This practical guide translates pH-resilience data into reproducible susceptibility workflows, preclinical model decisions, and troubleshooting strategies.
-
One-step TUNEL Cy3 Apoptosis Detection Kit Guide
2026-09-14
The One-step TUNEL Cy3 Apoptosis Detection Kit converts apoptotic DNA breaks into a microscopy- or flow-cytometry-compatible Cy3 signal across tissue sections and cultured cells. This practical guide connects assay setup, quantitative controls, and troubleshooting to translational colorectal cancer experiments.